These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7981338)

  • 21. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of inorganic phosphate in serum by double reagents with Hitachi 7170 A analyzer].
    Wang J; Jiang H
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):455-8. PubMed ID: 10073036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects.
    Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U
    Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of paraprotein interference in determination of plasma inorganic phosphate by ammonium molybdate method.
    Zaman Z; Sneyers L; Van Orshoven A; Blanckaert N; Mariën G
    Clin Chem; 1995 Apr; 41(4):609-14. PubMed ID: 7720254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.
    Rubel JR; Milford EL
    Am J Kidney Dis; 2003 Feb; 41(2):411-21. PubMed ID: 12552504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum sialic acid in patients with multiple myeloma.
    Crook MA; Couchman S; Tutt P
    Br J Biomed Sci; 1996 Sep; 53(3):185-6. PubMed ID: 8914343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Occurrence of hypophosphatemia in a Danish hospital population].
    Kayser L; Gravesen HS
    Ugeskr Laeger; 1991 Mar; 153(10):719-21. PubMed ID: 2008718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperphosphatemia in multiple myeloma.
    Oren S; Feldman A; Turkot S; Lugassy G
    Ann Hematol; 1994 Jul; 69(1):41-3. PubMed ID: 8061106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of serum anion gap in patients with HIV.
    Al-Aly Z; Valdez H; Moiz A; Bastani B
    J Nephrol; 2007; 20(6):727-30. PubMed ID: 18046675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
    Ayuk F; Perez-Simon JA; Shimoni A; Sureda A; Zabelina T; Schwerdtfeger R; Martino R; Sayer HG; Alegre A; Lahuerta JJ; Atanackovic D; Wolschke C; Nagler A; Zander AR; San Miguel JF; Kröger N
    Haematologica; 2008 Sep; 93(9):1343-50. PubMed ID: 18641030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low cobalamin (vitamin B12) levels in multiple myeloma: a retrospective study.
    Vlasveld LT
    Neth J Med; 2003 Aug; 61(8):249-52. PubMed ID: 14628959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference.
    Kazmierczak SC; Sekhon H; Richards C
    Int J Cardiol; 2005 May; 101(1):27-31. PubMed ID: 15860379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
    Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphate binding by a myeloma protein.
    Pettersson T; Hortling L; Teppo AM; Tötterman KJ; Fyhrquist F
    Acta Med Scand; 1987; 222(1):89-91. PubMed ID: 3115064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudohyperphosphataemia in multiple myeloma.
    McCloskey EV; Galloway J; Morgan MA; Kanis JA
    BMJ; 1989 Dec; 299(6712):1381-2. PubMed ID: 2513970
    [No Abstract]   [Full Text] [Related]  

  • 40. Spurious hypophosphatemia in a patient with multiple myeloma.
    Loghman-Adham M; Walton D; Iverius PH; Deiss A; Knight JA; Cheung AK
    Am J Kidney Dis; 1997 Oct; 30(4):571-5. PubMed ID: 9328375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.